258 related articles for article (PubMed ID: 23082177)
1. Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin.
Comenge J; Sotelo C; Romero F; Gallego O; Barnadas A; Parada TG; Domínguez F; Puntes VF
PLoS One; 2012; 7(10):e47562. PubMed ID: 23082177
[TBL] [Abstract][Full Text] [Related]
2. Effects of intermolecular interactions on the stability of carbon nanotube-gold nanoparticle conjugates in solution.
Konczak L; Narkiewicz-Michalek J; Pastorin G; Panczyk T
Int J Nanomedicine; 2016; 11():5837-5849. PubMed ID: 27853368
[TBL] [Abstract][Full Text] [Related]
3. Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery.
Aryal S; Hu CM; Zhang L
ACS Nano; 2010 Jan; 4(1):251-8. PubMed ID: 20039697
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
Shi Y; Goodisman J; Dabrowiak JC
Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
[TBL] [Abstract][Full Text] [Related]
5. Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy.
Keshavarz M; Moloudi K; Paydar R; Abed Z; Beik J; Ghaznavi H; Shakeri-Zadeh A
J Biomater Appl; 2018 Aug; 33(2):161-169. PubMed ID: 29933708
[TBL] [Abstract][Full Text] [Related]
6. Dumbbell-like Au-Fe3O4 nanoparticles for target-specific platin delivery.
Xu C; Wang B; Sun S
J Am Chem Soc; 2009 Apr; 131(12):4216-7. PubMed ID: 19275156
[TBL] [Abstract][Full Text] [Related]
7. Gold nanoconjugates reinforce the potency of conjugated cisplatin and doxorubicin.
Iram S; Zahera M; Khan S; Khan I; Syed A; Ansary AA; Ameen F; Shair OHM; Khan MS
Colloids Surf B Biointerfaces; 2017 Dec; 160():254-264. PubMed ID: 28942160
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels.
Zhao X; Pan J; Li W; Yang W; Qin L; Pan Y
Int J Nanomedicine; 2018; 13():6207-6221. PubMed ID: 30349245
[TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery of Cisplatin by Gold Nanoparticles: The Influence of Nanocarrier Surface Modification Type on the Efficiency of Drug Binding Examined by CE-ICP-MS/MS.
Wróblewska AM; Milewska A; Drozd M; Matczuk M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216438
[TBL] [Abstract][Full Text] [Related]
10. Exploring the binding of Pt drugs to gold nanoparticles for controlled passive release of cisplatin.
Comenge J; Romero FM; Sotelo C; Domínguez F; Puntes V
J Control Release; 2010 Nov; 148(1):e31-2. PubMed ID: 21529607
[No Abstract] [Full Text] [Related]
11. Enhanced cytotoxic activity of bile acid cisplatin derivatives by conjugation with gold nanoparticles.
Sánchez-Paradinas S; Pérez-Andrés M; Almendral-Parra MJ; Rodríguez-Fernández E; Millán A; Palacio F; Orfao A; Criado JJ; Fuentes M
J Inorg Biochem; 2014 Feb; 131():8-11. PubMed ID: 24239907
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
13. Charge-Convertible Carbon Dots for Imaging-Guided Drug Delivery with Enhanced in Vivo Cancer Therapeutic Efficiency.
Feng T; Ai X; An G; Yang P; Zhao Y
ACS Nano; 2016 Apr; 10(4):4410-20. PubMed ID: 26997431
[TBL] [Abstract][Full Text] [Related]
14. Surface Modification of Cisplatin-Complexed Gold Nanoparticles and Its Influence on Colloidal Stability, Drug Loading, and Drug Release.
Tan J; Cho TJ; Tsai DH; Liu J; Pettibone JM; You R; Hackley VA; Zachariah MR
Langmuir; 2018 Jan; 34(1):154-163. PubMed ID: 29141149
[TBL] [Abstract][Full Text] [Related]
15. Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies.
Bao H; Zhang Q; Xu H; Yan Z
Int J Nanomedicine; 2016; 11():929-40. PubMed ID: 27022260
[TBL] [Abstract][Full Text] [Related]
16. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.
Dhar S; Daniel WL; Giljohann DA; Mirkin CA; Lippard SJ
J Am Chem Soc; 2009 Oct; 131(41):14652-3. PubMed ID: 19778015
[TBL] [Abstract][Full Text] [Related]
17. Structure-Switchable DNA Programmed Disassembly of Nanoparticles for Smart Size Tunability and Cancer-Specific Drug Release.
Ye W; Chen X; Li X; Liu Y; Jia F; Jin Q; Ji J
ACS Appl Mater Interfaces; 2020 May; 12(20):22560-22571. PubMed ID: 32338490
[TBL] [Abstract][Full Text] [Related]
18. Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics.
Kim J; Lee YM; Kang Y; Kim WJ
ACS Nano; 2014 Sep; 8(9):9358-67. PubMed ID: 25184691
[TBL] [Abstract][Full Text] [Related]
19. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer.
Bortot B; Mongiat M; Valencic E; Dal Monego S; Licastro D; Crosera M; Adami G; Rampazzo E; Ricci G; Romano F; Severini GM; Biffi S
Int J Nanomedicine; 2020; 15():4793-4810. PubMed ID: 32764921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
